z-logo
open-access-imgOpen Access
Octreotide treatment in a neonate with non-chylous pleural effusion
Author(s) -
Salih Kalay,
Osman Öztekin,
Gönül Tezel,
BurakEmre Demir,
Mustafa Akçakuş,
Nihal Oygür
Publication year - 2013
Publication title -
african journal of paediatric surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.163
H-Index - 17
eISSN - 0189-6725
pISSN - 0974-5998
DOI - 10.4103/0189-6725.125452
Subject(s) - medicine , thoracentesis , octreotide , chylothorax , pleural effusion , pleurodesis , chylous ascites , thoracostomy , surgery , effusion , ascites , somatostatin , pneumothorax
Fetal pleural effusion is a rare condition. While it may regress spontaneously, it may also continue up to the post-natal period. This condition may be treated by thoracentesis, thoracoabdominal shunt application and pleurodesis in the intrauterine period while thoracentesis or tube thoracostomy may be used in the post-natal period. In cases where the fluid is defined to represent chylothorax, octreotide, a somatostatin analogue, may be administered for treatment. In this case report, we discussed the outcomes of treatment with octreotide administered in a neonatal case under follow-up due to fetal pleural effusion and with non-chylous ascites detected in the post-natal period.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom